Postantibiotic effects of subinhibitory concentrations of some antibiotics and their influence on Pseudomonas aeruginosa enzymic activity
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
9090822
DOI
10.1007/bf02816338
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- antiinfekční látky farmakologie MeSH
- ciprofloxacin farmakologie MeSH
- endopeptidasy účinky léků metabolismus MeSH
- gentamiciny farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- netilmicin farmakologie MeSH
- pankreatická elastasa účinky léků metabolismus MeSH
- Pseudomonas aeruginosa účinky léků enzymologie MeSH
- tobramycin farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antibakteriální látky MeSH
- antiinfekční látky MeSH
- ciprofloxacin MeSH
- endopeptidasy MeSH
- gentamiciny MeSH
- netilmicin MeSH
- pankreatická elastasa MeSH
- tobramycin MeSH
The postantibiotic effects of subinhibitory concentrations (PA SMEs) and virulence factor alterations induced by ciprofloxacin, tobramycin and netilmicin in Pseudomonas aeruginosa were studied. After induction of the postantibiotic phase (PA) (2x or 4x MIC) the cultures were exposed to subinhibitory concentrations (0.1, 0.2 and 0.3x MIC) of the same antibiotic (PA SME). The regrowth of treated as well as control cultures was followed for 24 or 45 h. In the sterile culture filtrates obtained from these bacterial cultures, elastase and proteinase were determined. Ciprofloxacin and aminoglycosides exhibited PA SMEs of 35-35 h for certain combinations of supra-subinhibitory antibiotic concentrations. Longer PA SMEs were observed after treatment with higher sub-MICs. Tobramycin at 0.2 and 0.3x MIC (postantibiotic phase induced by 2x MIC) and at alt sub-MICs added to the bacteria previously exposed to 4x MIC do not allow any regrowth of bacterial culture. PA SMEs of tested antibiotics affected virulence factors of P. aeruginosa. Elastase compared to proteinase was suppressed more effectively. Ciprofloxacin at 0.3x MIC reduced elastase and proteinase activity most significantly (to 14.2 and 60% of the control values).
Zobrazit více v PubMed
J Antimicrob Chemother. 1981 Nov;8 Suppl C:81-91 PubMed
J Antimicrob Chemother. 1990 Jul;26(1):29-38 PubMed
Zentralbl Bakteriol. 1996 Mar;283(3):322-7 PubMed
Chemotherapy. 1994 Jan-Feb;40(1):30-6 PubMed
Scand J Infect Dis Suppl. 1989;58:1-55 PubMed
Chemotherapy. 1992;38(6):388-94 PubMed
J Antimicrob Chemother. 1994 Dec;34(6):921-30 PubMed
Antimicrob Agents Chemother. 1989 Jan;33(1):41-7 PubMed
Antimicrob Agents Chemother. 1992 Sep;36(9):1852-8 PubMed
J Infect Dis. 1977 Feb;135(2):217-23 PubMed
J Bacteriol. 1973 Oct;116(1):25-32 PubMed
Antimicrob Agents Chemother. 1993 Oct;37(10):2200-5 PubMed